Danieley Joan 4
4 · agilon health, inc. · Filed Dec 17, 2021
Insider Transaction Report
Form 4
Danieley Joan
Chief Administrative Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-16$4.45/sh+3,519$15,660→ 8,953 total - Sale
Common Stock
2021-12-15$22.58/sh−15,321$345,948→ 15,113 total - Exercise/Conversion
Options (Rights to Buy)
2021-12-15−25,000→ 75,000 totalExercise: $4.45Exp: 2030-01-31→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2021-12-15$4.45/sh+25,000$111,250→ 30,434 total - Sale
Common Stock
2021-12-15$23.29/sh−9,679$225,424→ 5,434 total - Sale
Common Stock
2021-12-16$23.14/sh−3,519$81,430→ 5,434 total - Exercise/Conversion
Options (Rights to Buy)
2021-12-16−3,519→ 71,481 totalExercise: $4.45Exp: 2030-01-31→ Common Stock (3,519 underlying)
Footnotes (5)
- [F1]Includes restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.92 to $22.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.96 to $23.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.03 to $23.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]These options were granted on January 31, 2020 and are scheduled to vest in four equal installments on each anniversary of August 13, 2019, subject to continued employment.